236 related articles for article (PubMed ID: 24564623)
1. Increased prevalence of early cochlear damage in young patients with type 1 diabetes detected by distortion product otoacoustic emissions.
Botelho CT; Carvalho SA; Silva IN
Int J Audiol; 2014 Jun; 53(6):402-8. PubMed ID: 24564623
[TBL] [Abstract][Full Text] [Related]
2. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
Hoth S
Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
[TBL] [Abstract][Full Text] [Related]
3. Early Indices of Reduced Cochlear Function in Young Adults with Type-1 Diabetes Revealed by DPOAE Fine Structure.
Spankovich C; Long GR; Hood LJ
J Am Acad Audiol; 2019 Jun; 30(6):459-471. PubMed ID: 30461415
[TBL] [Abstract][Full Text] [Related]
4. Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM.
Di Nardo W; Ghirlanda G; Paludetti G; Cercone S; Saponara C; Del Ninno M; Di Girolamo S; Magnani P; Di Leo MA
Diabetes Care; 1998 Aug; 21(8):1317-21. PubMed ID: 9702440
[TBL] [Abstract][Full Text] [Related]
5. Diagnostics of the cochlear amplifier by means of distortion product otoacoustic emissions.
Janssen T; Niedermeyer HP; Arnold W
ORL J Otorhinolaryngol Relat Spec; 2006; 68(6):334-9. PubMed ID: 17065826
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients.
Oliveira Bezerra DC; Oliveira de Barcelos R; Carvalho de Castro E; Jardim Duarte CC; de Vasconcellos Carvalhaes Oliveira R; Salgado de Sousa Torraca T; de Araújo-Melo MH; Pereira Bom Braga F; Ramos Ferreira Terceiro B; do Nascimento Brahim Paes LR; de Oliveira Schubach A; Valete-Rosalino CM
PLoS One; 2017; 12(1):e0168492. PubMed ID: 28045920
[TBL] [Abstract][Full Text] [Related]
7. Transiently evoked and distortion-product otoacoustic emissions. Comparison of results from normally hearing and hearing-impaired human ears.
Probst R; Harris FP
Arch Otolaryngol Head Neck Surg; 1993 Aug; 119(8):858-60. PubMed ID: 8343248
[TBL] [Abstract][Full Text] [Related]
8. Distortion product otoacoustic emissions and sensorineural hearing loss.
Moulin A; Bera JC; Collet L
Audiology; 1994; 33(6):305-26. PubMed ID: 7741665
[TBL] [Abstract][Full Text] [Related]
9. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
[TBL] [Abstract][Full Text] [Related]
10. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
11. Distortion product otoacoustic emission and auditory brain stem response measures of pediatric sensorineural hearing loss with islands of normal sensitivity.
Balfour PB; Pillion JP; Gaskin AE
Ear Hear; 1998 Dec; 19(6):463-72. PubMed ID: 9867294
[TBL] [Abstract][Full Text] [Related]
12. Cochlear involvement in Familial Mediterranean Fever: a new feature of an old disease.
Koybasi S; Atasoy Hİ; Bicer YO; Tug E
Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):244-7. PubMed ID: 22177320
[TBL] [Abstract][Full Text] [Related]
13. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
Schlögel H; Stephan K; Böheim K; Welzl-Müller K
HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
[TBL] [Abstract][Full Text] [Related]
14. Input-output functions of the nonlinear-distortion component of distortion-product otoacoustic emissions in normal and hearing-impaired human ears.
Zelle D; Lorenz L; Thiericke JP; Gummer AW; Dalhoff E
J Acoust Soc Am; 2017 May; 141(5):3203. PubMed ID: 28599560
[TBL] [Abstract][Full Text] [Related]
15. Cochlear, auditory brainstem responses in Type 1 diabetes: relationship with metabolic variables and diabetic complications.
Lasagni A; Giordano P; Lacilla M; Raviolo A; Trento M; Camussi E; Grassi G; Charrier L; Cavallo F; Albera R; Porta M; Zanone MM
Diabet Med; 2016 Sep; 33(9):1260-7. PubMed ID: 26605750
[TBL] [Abstract][Full Text] [Related]
16. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
Rosner T; Kandzia F; Oswald JA; Janssen T
J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet's disease.
Dagli M; Eryilmaz A; Tanrikulu S; Aydin A; Gonul M; Gul U; Gocer C
Auris Nasus Larynx; 2008 Sep; 35(3):333-7. PubMed ID: 17996415
[TBL] [Abstract][Full Text] [Related]
18. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of cochlear active mechanisms in tinnitus subjects with normal hearing sensitivity: multiparametric recording of evoked otoacoustic emissions and contralateral suppression.
Paglialonga A; Del Bo L; Ravazzani P; Tognola G
Auris Nasus Larynx; 2010 Jun; 37(3):291-8. PubMed ID: 19879078
[TBL] [Abstract][Full Text] [Related]
20. Click-evoked otoacoustic emissions and hearing threshold in sensorineural hearing loss.
Collet L; Levy V; Veuillet E; Truy E; Morgon A
Ear Hear; 1993 Apr; 14(2):141-3. PubMed ID: 8472879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
